These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses. Nadeem HS; Attenburrow MJ; Cowen PJ Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082 [TBL] [Abstract][Full Text] [Related]
6. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. Seifritz E; Müller MJ; Annen O; Nil R; Hatzinger M; Hemmeter U; Moore P; Holsboer-Trachsler E J Psychiatr Res; 1997; 31(5):543-54. PubMed ID: 9368196 [TBL] [Abstract][Full Text] [Related]
7. Administration of citalopram before ECT: seizure duration and hormone responses. Papakostas YG; Markianos M; Zervas IM; Theodoropoulou M; Vaidakis N; Daras M J ECT; 2000 Dec; 16(4):356-60. PubMed ID: 11314873 [TBL] [Abstract][Full Text] [Related]
8. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Kilkens TO; Honig A; Fekkes D; Brummer RJ Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497 [TBL] [Abstract][Full Text] [Related]
9. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI. Lowe SL; Yeo KP; Teng L; Soon DK; Pan A; Wise SD; Peck RW Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695 [TBL] [Abstract][Full Text] [Related]
11. Citalopram challenge in social anxiety disorder. Shlik J; Maron E; Tru I; Aluoja A; Vasar V Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063 [TBL] [Abstract][Full Text] [Related]
12. S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants. Kuepper Y; Bausch S; Iffland J; Reuter M; Hennig J Psychoneuroendocrinology; 2006 Nov; 31(10):1200-7. PubMed ID: 17123742 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans. Berardelli R; Margarito E; Ghiggia F; Picu A; Balbo M; Bonelli L; Giordano R; Karamouzis I; Bo M; Ghigo E; Arvat E J Endocrinol Invest; 2010 Oct; 33(9):657-62. PubMed ID: 20414043 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers. Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471 [TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences. Lotrich FE; Bies R; Muldoon MF; Manuck SB; Smith GS; Pollock BG Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685 [TBL] [Abstract][Full Text] [Related]
16. Acute hormonal changes after IV citalopram and treatment response in OCD. Corregiari FM; Gattaz WF; Bernik M Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272 [TBL] [Abstract][Full Text] [Related]
17. Specific effects of escitalopram on neuroendocrine response. Hawken ER; Owen JA; Hudson RW; Delva NJ Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384 [TBL] [Abstract][Full Text] [Related]
18. A bioequivalence study of citalopram based on quantification by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Mendes GD; Borges NC; Pereira Ados S; Mendes FD; Barrientos-Astigarraga RE; De Nucci G Int J Clin Pharmacol Ther; 2005 Aug; 43(8):389-98. PubMed ID: 16119514 [TBL] [Abstract][Full Text] [Related]